Real-time enrollment status for this advanced hepatocellular carcinoma clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 5:33 PM UTC
| NCT Number | NCT06600321 |
| Recruiting Status | Recruiting |
| Condition | Advanced Hepatocellular Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 158 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Alnylam Pharmaceuticals |
| Last Updated on CT.gov | June 17, 2026 (Jun 17, 2026) |
As of August 27, 2026: Clinical trial NCT06600321 is currently recruiting participants. This phase1 study for advanced hepatocellular carcinoma is actively seeking new participants at 16 locations across the United States. The study is sponsored by Alnylam Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06600321 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06600321 was last updated Jun 17, 2026 (June 17, 2026). HelloStudys verifies this status automatically.